Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Labile Blood Components by Using Nucleic Acid Targeted Methods
-
Published:2001
Issue:
Volume:
Page:113-123
-
ISSN:
-
Container-title:Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected
-
language:
-
Short-container-title:
Reference66 articles.
1. Dodd RY. Will blood products be free of infectious agents? In: Nance SJ, ed. Transfusion Medicine In The 1990’s. Arlington,VA: American Association of Blood Banks, 1990:223–51.
2. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas’ disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991;31:547–57.
3. Grant IH, Gold JMW, Wittner M, et al. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989;111: 849–51.
4. Nickerson P, On P, Schroeder ML, Sekla L, Johnston JB. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989;111:85153.
5. Mintz ED, Anderson JF, Cable RG, Hadler IL. Transfusion-transmitted babesiosis: a case report from a new endemic area. Transfusion 1991;31:365–68.